期刊文献+

苏云金芽孢杆菌重组L-异亮氨酸羟化酶的酶学性质及其在4-羟基异亮氨酸合成中的应用 被引量:10

Characterization of recombinant L-isoleucine-4-hydroxylase from Bacillus thuringiensis and its application in 4-hydroxyisoleucine biosynthesis
原文传递
导出
摘要 【目的】克隆并表达来源于苏云金芽孢杆菌(Bacillus thuringiensis)TCCC 11826的L-异亮氨酸羟化酶(L-isoleucine-4-hydroxylase,IDO),测定重组IDO酶学特性并构建用于4-羟基异亮氨酸(4-Hydroxyisoleucine,4-HIL)微生物转化的重组菌株,以考察该酶在4-HIL合成中的潜在应用价值。【方法】以B.thuringiensis TCCC 11826基因组为模板PCR扩增ido基因并构建该基因过表达菌株BL-IDO;采用Ni-NTA亲和层析法分离纯化重组IDO后检测其酶学特性;构建重组株菌W3110-IDO进行4-HIL的微生物转化。【结果】克隆B.thuringiensis TCCC 11826的ido基因,测序结果显示该基因含723个核苷酸,编码240个氨基酸,与已报道的B.thuringiensis 2-e-2的ido基因相似度分别为97.47%和97.91%。此IDO含有His1-X-Asp/Glu-Xn-His2基序,属于Fe2+和α-酮戊二酸依赖型羟化酶家族;酶学实验表明该酶能够特异性地催化L-异亮氨酸生成(2S,3R,4S)-4-HIL,其Km和Vm ax分别为0.18 mmol/L和2.10μmol/min/mg,最适反应温度和pH分别为35℃和7.0,该酶于35℃条件下放置5 h后仍具有85.1%的活性;在Escherichia coli W3110中过表达重组IDO,在未经优化条件下4-HIL最高转化率达89.28%。【结论】获得IDO编码基因序列(Accession No.KC884243)并首次较为系统地研究了其酶学特性,该酶反应条件温和且具有较高的活性及稳定性,在酶法或微生物转化法合成4-HIL中有较广泛的应用价值。本研究可为4-HIL及其它氨基酸衍生物的生物制造技术奠定理论基础。 [ Objective ] L-isoleucine-4-hydroxylase (IDO) encoding gene ido from Bacillus thuringiensis TCCC 11826 was cloned and expressed, followed by enzyme characterization. In addition, recombinant strain was tested for its 4- Hydroxyisoleucine (4-HIL) biotransformation. [ Methods] Ido gene was amplified from B. thuringiensis TCCC 11826 genomic DNA and expressed in BL-IDO. Recombinant IDO was extracted, purified and characterized. Recombinant strain used for biotransformation of 4-HIL was constructed. [ Results ] Composed of 723 nucleotides encoding 240 amino acids (sharing 97.47% and 97.91% identities with that of B. thuringiensis 2-e-2), ido gene was cloned from B. thuringiensis TCCC 11826. The recombinant IDO contained a His1-X-Asp/Glu-Xn-His2 motif that is specific for Fe(II)/α-ketoglutarate- dependent hydroxylases and catalyzed L-isoleucine to 4-HIL. Normal hyperbolic kinetics was observed with L-Ile in the reaction by recombinant IDO. Lineweaver-Burk treatment of the data yielded apparent K and the Vmox was 0. 18 mmol/L and 2. 10 p.mol/min/mg, respectively. The optimum temperature and pH for the recombinant IDO was 35℃ and 7.0 respectively; moreover, the relative activity of the enzyme remain 85.10% after 5 h incubation at 35℃. In all, recombinant strain harboring ido transformed 89.28% of L-isoleucine to 4-HIL. [ Conclusion ] In this study, an ido ( Accession No. KC884243) with novel sequence was isolated and enzymatic characteristics of recombinant IDO was systematically analyzed. In addition, we successfully achieved the biotransformation of 4-HIL from L-isoleucine. This work will lay theoretical foundation and practical basis on the microbial manufacture technology of 4-HIL and other amino acid derivatives. This work will lay theoretical foundation and practical basis on the microbial manufacture technology of 4-HIL and other amino acid derivatives.
出处 《微生物学报》 CAS CSCD 北大核心 2014年第8期889-896,共8页 Acta Microbiologica Sinica
基金 国家自然科学基金(31300069) 天津市科技支撑计划重点项目(12ZCZDSY01900)~~
关键词 4-羟基异亮氨酸 L-异亮氨酸羟化酶 酶学性质 苏云金芽孢杆菌 微生物转化 4-Hydroxyisoleucine, L-isoleucine-4-hydroxylase, enzymatic characteristics, Bacillus thuringiensis, microbial transformation
  • 相关文献

参考文献24

  • 1Fowden L, Pratt HM, Smith A. 4-Hydroxyisoleucine from seed of Trigonella foenum-graecum. Phytochemistry , 1973, 12(7): 1707-1711.
  • 2A1-Habori M, Raman A. Antidiabetic and hypocholesterolaemic effects of fenugreek. Phytotherapy Research, 1998, 12(4) : 233-242.
  • 3Sauvaire Y, Petit P, Broca C, Manteghetti M, Baissac Y, Fernandez-Alvarez J, Gross R, Roye M, Leconte A, Gomis R, Ribes G. 4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes, 1998, 47.(2) : 206-210.
  • 4Broca C, Manteghetti M, Gross R, Baissac Y, Jacob M, Petit P, Sauvaire Y, Ribes G. 4-Hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretion. European Journal of Pharmacology, 2000, 390 (3) : 339-345.
  • 5Broca C, Breil V, Cruciani-Guglielmaeei C, Manteghetti M, Rouault C, Derouet M, Rizkalla S, Pau B, Petit P, Ribes G, Ktorza A, Gross R, Reach G, Taouis M. Insulinotropic agent ID-1101 ( 4-hydroxyisoleueine ) activates insulin signaling in rat. American Journal of Physiology-Endocrinology and Metabolism, 2004, 287 (3) : 463-471.
  • 6Broca C, Gross R, Petit P, Sauvaire Y, Manteghetti M, Tournier M, Masiello P, Gomis R, Ribes G. 4- Hydroxyisoleucine : experimental evidence of its insulinotropic and antidiabetie properties. American Journal of Physiology-Endocrinology and Metabolism, 1999, 277(4): 617-623.
  • 7Narender T, Puri A, Shweta, Khaliq T, Saxena R, Bhatia G, Chandra R. 4-hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemie agent. Bioorganic & Medicinal Chemistry Letters, 2006, 16(2) :293-296.
  • 8Haeri MR, Limaki HK, White CJ, White KN. Non- insulin dependent anti-diabetic activity of (2S, 3R, 4S)- 4-hydroxyisoleucine of fenugreek ( Trigonella foenumgraecum) in streptozotoein -induced type I diabetic rats. Phytomedicine, 2012, 19 (7) : 571-574.
  • 9Jaiswal N, Maurya CK, Venkateswarlu K, Sukanya P, Srivastava AK, Narender T, Tamrakar AK. 4- Hydroxyisoleucine stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells viaphosphatidylinositol-3-kinase-dependent pathway. European Journal of Nutrition, 2012, 51 (7) : 893-898.
  • 10Haeri MR, Izaddoost M, Ardekani MR, Nobar MR, White KN. The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats. Phytotherapy Research, 2009, 23 ( 1 ) : 61-64.

共引文献7

同被引文献18

引证文献10

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部